Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Number of holders
-
110
-
Total 13F shares, excl. options
-
2,930,364
-
Shares change
-
-53,464
-
Total reported value, excl. options
-
$291,496,084
-
Value change
-
-$4,711,885
-
Put/Call ratio
-
62%
-
Number of buys
-
42
-
Number of sells
-
56
-
Price
-
$99.71
Institutional Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q3 2016
As of 30 Sep 2016 FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) had 127 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,930,364 shares of stock of the company.
Largest 10 holders included MORGAN STANLEY, WELLS FARGO & COMPANY/MN, BANK OF AMERICA CORP /DE/, UBS Group AG, AMERIPRISE FINANCIAL INC, RAYMOND JAMES & ASSOCIATES, LPL Financial LLC, ROYAL BANK OF CANADA, J&P(CHINA)CAPITAL MANAGEMENT CO.,LTD, and McKinley Carter Wealth Services, Inc..
This table shows 127 institutional shareholders of the security as of 30 Sep 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.